BLCO
Bausch + Lomb Corp.
NYSE · Healthcare · Medical - Instruments & Supplies · CA
$16.85
+0.48%0
Insider buys (3m)
3
Insider sells (3m)
-$1.2M
Net value (3m)
+12.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 14, 2026 | Chersi Robert J · director | A-Award | 11,776 | $0.00 |
| Aug 14, 2026 | PAUL LAURENCE E · director | A-Award | 11,776 | $0.00 |
| Aug 14, 2026 | Trebbi Barbara · director | A-Award | 11,776 | $0.00 |
| Aug 12, 2026 | Munsch Frederick · officer: SVP, Controller and CAO | Sale | 52,900 | $17 |
| Aug 10, 2026 | VON ESCHENBACH ANDREW C. · director | Sale | 6,059 | $17 |
| Aug 10, 2026 | VON ESCHENBACH ANDREW C. · director | Sale | 12,500 | $17 |
| Aug 7, 2026 | SAUNDERS BRENT L · director, officer: Chairman of the Board and CEO | A-Award | 281,879 | $0.00 |
| Aug 7, 2026 | SAUNDERS BRENT L · director, officer: Chairman of the Board and CEO | F-InKind | 4,231 | $17 |
| Aug 7, 2026 | Bailey A Robert D · officer: EVP & Chief Legal Officer | A-Award | 33,557 | $0.00 |
| Aug 7, 2026 | Bonnefoy Luc · officer: President, Surgical | A-Award | 16,778 | $0.00 |
| Aug 7, 2026 | Eldessouky Sam · officer: EVP and CFO | A-Award | 50,335 | $0.00 |
| Aug 7, 2026 | Hashad Yehia · officer: EVP of R&D and CMO | A-Award | 20,973 | $0.00 |
| Aug 7, 2026 | Munsch Frederick · officer: SVP, Controller and CAO | A-Award | 9,091 | $0.00 |
| Aug 7, 2026 | Stewart Andrew J. · officer: President, GPIC | A-Award | 16,778 | $0.00 |
| Jun 16, 2026 | Bonnefoy Luc · officer: President, Surgical | F-InKind | 1,008 | $15 |
| May 28, 2026 | COLLIS STEVEN H · director | A-Award | 15,842 | $16 |
| May 28, 2026 | VON ESCHENBACH ANDREW C. · director | A-Award | 15,842 | $16 |
| May 28, 2026 | Ross Thomas W. Sr. · director | A-Award | 15,842 | $16 |
| May 28, 2026 | ROBERTSON RUSSEL C · director | A-Award | 15,842 | $16 |
| May 28, 2026 | Paulson John · director | A-Award | 15,842 | $16 |
| May 28, 2026 | Ling Karen · director | A-Award | 15,842 | $16 |
| May 28, 2026 | KAVANAGH SARAH B · director | A-Award | 15,842 | $16 |
| May 28, 2026 | Bernier Nathalie D. · director | A-Award | 15,842 | $16 |
| May 28, 2026 | Alfonso Eduardo · director | A-Award | 15,842 | $16 |
| May 26, 2026 | SAUNDERS BRENT L · director, officer: Chairman of the Board and CEO | F-InKind | 2,886 | $16 |
| May 7, 2026 | Hashad Yehia · officer: EVP of R&D and CMO | F-InKind | 13,664 | $16 |
| May 7, 2026 | Munsch Frederick · officer: SVP, Controller and CAO | F-InKind | 8,673 | $16 |
| May 7, 2026 | Eldessouky Sam · officer: EVP and CFO | F-InKind | 63,938 | $16 |
| May 7, 2026 | Bonnefoy Luc · officer: President, Surgical | F-InKind | 11,970 | $16 |
| May 1, 2026 | Alfonso Eduardo · director | A-Award | 1,375 | $16 |
Institutional positioning
13F filings over the trailing two quarters
New 37Increased 63Reduced 61Sold out 15
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DEUTSCHE BANK AG\ | Increased | 3,528,441 | May 6, 2026 |
| ICAHN CARL C | Unchanged | 3,500,000 | Aug 14, 2026 |
| ICAHN CARL C | Unchanged | 3,500,000 | May 15, 2026 |
| OAKTREE CAPITAL MANAGEMENT LP | Increased | 3,441,042 | Aug 14, 2026 |
| DEUTSCHE BANK AG\ | Reduced | 3,423,046 | Aug 7, 2026 |
| OAKTREE CAPITAL MANAGEMENT LP | Unchanged | 3,382,739 | May 20, 2026 |
| D. E. Shaw & Co., Inc. | Increased | 3,323,021 | Aug 14, 2026 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | Increased | 3,158,972 | Aug 14, 2026 |
| D. E. SHAW & CO., INC. | Increased | 3,151,167 | May 15, 2026 |
| GOLDENTREE ASSET MANAGEMENT LP | Unchanged | 2,660,508 | May 14, 2026 |
| GOLDENTREE ASSET MANAGEMENT LP | Unchanged | 2,660,508 | Aug 14, 2026 |
| SILVER POINT CAPITAL L.P. | Reduced | 2,245,000 | May 15, 2026 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | Increased | 2,199,172 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 2,161,232 | Aug 14, 2026 |
| CASPIAN CAPITAL LP | Unchanged | 1,999,043 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 14, 2026